Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...

The American Association for Cancer Research’s annual conference continued Monday with Roche offering a postmortem for its ...